Health News Archive - February 27, 2009
SEATTLE, Feb. 27 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
- Expands Beckman Coulter's Worldwide Position in Clinical Chemistry - Complementary Market Positions and Product Portfolios in Chemistry and Automation Broaden Global Opportunity, Increase Customer Choice - Penetration of Beckman Coulter's Immunoassay Products into Olympus' Installed Chemistry Base Supports Continued Above-Market Growth - Transaction Expected to be Accretive to Non-GAAP Earnings Per Share in 2010 ORANGE COUNTY, Calif., Feb.
A University of Missouri team of scientists identified the location of the genetic material vital to curing muscular dystrophy. Dongsheng Duan said Duchenne muscular dystrophy, which predominantly affects males, is the most common type of muscular dystrophy.
TUCSON, Ariz., Feb.
KING OF PRUSSIA, Pa., Feb.
DALLAS, Feb. 27 /PRNewswire-USNewswire/ -- For the past three years, 46-year-old Abel Espinoza managed his diabetes by going to the emergency room. With no access to a physician, medication or medical supplies, he only received treatment when it became absolutely necessary.
BRANFORD, Conn., Feb. 27 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN) announced today that it is creating the new position of Executive Chairman of the Board and is naming current board member Mr. John H.
CHICAGO, Feb. 27 /PRNewswire/ -- Novalar Pharmaceuticals, Inc., a dental specialty pharmaceutical company today announced the launch of OraVerse(TM), the company's premier dental pharmaceutical product.
NEW YORK, Feb. 27 /PRNewswire-FirstCall/ -- Care Investment Trust Inc.